Where scientists push the boundaries of human knowledge to solve humanity’s most pressing health challenges. Unique drug discovery tools enable researchers to go further, and seek potential treatments for diseases with unmet needs.| The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
Cutting-edge immunology applied to cancer, HIV, autoimmunity, inflammation, SARS-CoV-2 and beyond. The Immunology and Microbiology faculty of The Wertheim UF Scripps Institute are devoted to explaining how the immune system functions, how diseases spread and evolve, and designing new treatments and cures for infectious disease, cancer and autoimmune disorders. We pair foundational biological research with…| The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
The protein called p32 might provide a potential target for drugs that keep HIV dormant and harmless. It was discovered by Susana Valente, Ph.D.| wertheim.scripps.ufl.edu
Fifteen high school students from Palm Beach and Martin counties celebrated their summer of accomplishment aat the Glenn W. Bailey STEM Education & Outreach Programs Kenan Fellows Summer Symposium.| The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Tec...
Viruses infect cells with a goal of taking control to churn out new viral copies. Cells have learned to fight back.| The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Tec...
A new study in Nature that finds a gene therapy against HIV given at birth can protect breastfeeding babies from infection with a single dose.| wertheim.scripps.ufl.edu
A new discovery from the lab of chemist Matthew Disney, Ph.D., takes its inspiration from Greek mythology. The compound is a chimera, and it battles a toxic cause of Parkinson's in two ways.| wertheim.scripps.ufl.edu
Where scientists push the boundaries of human knowledge to solve humanity’s most pressing health challenges. Unique drug discovery tools enable researchers to go further, and seek potential treatments for diseases with unmet needs.| wertheim.scripps.ufl.edu
Liu’s research focuses on the discovery of small molecules for human proteins, as well as the functional characterization of these proteins in physiological and disease contexts.| wertheim.scripps.ufl.edu
My scientific career has focused on the study of protein structure and approaches to modulating protein function via synthetic small molecules with a focus on nuclear receptors. I have a broad background in drug discovery and development that spans the last 25+ years. I received a Ph.D. in Chemistry from the University of Virginia under the direction of Professor Donald F. Hunt where I was involved in methodology development in the field of Biological Mass Spectrometry. After graduating from ...| The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
Where scientists push the boundaries of human knowledge to solve humanity’s most pressing health challenges. Unique drug discovery tools enable researchers to go further, and seek potential treatments for diseases with unmet needs.| The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
Where scientists push the boundaries of human knowledge to solve humanity’s most pressing health challenges. Unique drug discovery tools enable researchers to go further, and seek potential treatments for diseases with unmet needs.| The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
Rumbaugh lab found that the gene Syngap1 enables normally quiet neurons to spring into activity during sensory challenges, while other neurons are quieted.| wertheim.scripps.ufl.edu
A Parkinson's disease project from the lab of chemist Matthew D. Disney, Ph.D., has received a boost from a nonprofit focused on helping scientists translate their discoveries into treatments.| wertheim.scripps.ufl.edu
A cancer-killing compound, called tiancimycin, combined with a cancer-seeking antibody, shows promise against an aggressive type of lymphoma.| The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Tec...
Half of glioblastoma patients have a subtype that doesn’t respond to any approved cancer drugs. A new experimental treatment from The Wertheim UF Scripps Institute shows promise in mouse studies. Clinical trials are coming soon.| The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Tec...
One in five of our faculty holds a prestigious R35 Outstanding Investigator Award from the National Institutes of Health.| wertheim.scripps.ufl.edu
“The great biosynthetic potential of nature has been explored in a limited way until now. By advancing the technologies needed to sequence large strain collections, such as the one here, we can begin to realize the full potential of this resource to benefit humanity.” Ben Shen, Ph.D. Opening nature’s biodiversity to science More than one-third…| wertheim.scripps.ufl.edu
The eighth graders heard from Wertheim UF Scripps postdoctoral researchers, graduate students and interns studying a variety of aspects of health and disease.| wertheim.scripps.ufl.edu
Fifteen talented high school students from Palm Beach and Martin counties are conducting research at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology this summer. The students‘ full-time internships are made possible thanks to generous donations from the William R. Kenan, Jr. Charitable Trust and the Glenn W. Bailey Foundation. Last week…| The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Tec...
Nearly 600 students applied for 10 Summer Undergraduate Research Fellows internship slots this year, said Rosie Albarran Zeckler, Ph.D. Meet the 2025 college interns.| wertheim.scripps.ufl.edu
"Discovering new medicines is challenging work that requires the expertise of many. There are real synergies for our scientists and students as we build collaboration among departments," said Matthew Disney, Ph.D., chair of The Wertheim UF Scripps chemistry department.| wertheim.scripps.ufl.edu
Children born with a damaged gene needed for healthy brain development, SYNGAP1, experience seizures, sensory processing disorders, difficulty speaking, intellectual disability, and autism-like behaviors. It’s a condition without any treatments, one that’s hard both on parents and children, said Gavin Rumbaugh, Ph.D., a neuroscientist at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation &…| wertheim.scripps.ufl.edu
Scripps Research awarded doctoral degrees to 59 graduate students, including eight from its partner program based at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, during its 32nd commencement.| wertheim.scripps.ufl.edu
